Issue Cover

Industry Insights

A deeper dive into the pharmaceutical industry

Articles

Don’t settle for black box: why only explainable AI is built for scientific discovery
Don’t settle for black box: why only explainable AI is built for scientific discovery

Lykke Pedersen from Abzu considers the benefits of AI and its different applications within the pharma industry

7 February 2024Industry Insights
The risk of replicating social bias in synthetic patients – the need for human intelligence with AI
The risk of replicating social bias in synthetic patients – the need for human intelligence with AI

Paul Reed and Annabelle Gall at Research Partnership, an Inizio Advisory company, consider the benefits and drawbacks of AI, especially in terms of diversity and synthetic patients

7 February 2024Industry Insights
2024: a tipping point for progress in rare diseases?
2024: a tipping point for progress in rare diseases?

Soraya Bekkali from Alexion, AstraZeneca Rare Disease, explains why the EU must act in 2024 to tackle the health equity crisis that people living with rare diseases face every day

7 February 2024Industry Insights
The impact of climate change on respiratory health
The impact of climate change on respiratory health

With the first ever COP health event being held in December 2023, Shishir Patel from Chiesi UK and Ireland reflects on the need to align environmental and health strategies and shares his work building a clearer picture of how climate change can impact respiratory health

7 February 2024Industry Insights
Paediatrics in the review of the EU General Pharmaceutical Legislation
Paediatrics in the review of the EU General Pharmaceutical Legislation

Pauline Roudot from Novartis considers the path to approval for paediatric medications

7 February 2024Industry Insights
Embracing technological advancements: revolutionising clinical trials through remote capabilities
Embracing technological advancements: revolutionising clinical trials through remote capabilities

Dr Harsha Rajasimha from Jeeva Informatics considers how digital innovations and decentralisation can improve clinical trials

24 November 2023Industry Insights
Anti-counterfeiting: the battle against fake pharmaceuticals
Anti-counterfeiting: the battle against fake pharmaceuticals

Steve Brownett-Gale, marketing lead at Origin, considers how to combat counterfeiting in the pharma industry

24 November 2023Industry Insights
Notable tech-enabled solutions advancing clinical trials with all stakeholders in mind
Notable tech-enabled solutions advancing clinical trials with all stakeholders in mind

Monika Lamba Saini, Greg Lever and Ashley Polhemus from IQVIA and Q2 Solutions explore digital health technologies and their use in clinical trials

24 November 2023Industry Insights
The role of digital therapeutics in central nervous system clinical trials
The role of digital therapeutics in central nervous system clinical trials

Louisa Steinberg and Maureen Glynn from ICON consider the role of digital therapeutics in the treatment of central nervous system conditions and how they can be used to improve clinical trials

1 November 2023Industry Insights
How AI can advance today’s complex biopharma launch landscape
How AI can advance today’s complex biopharma launch landscape

Florian Schnappauf from Veeva tells Pharmafocus about the role of generative AI in life sciences sales and marketing and how it can help bring new medicines to market faster

5 October 2023Industry Insights
Unlocking science to discover novel solutions for breast cancer patients
Unlocking science to discover novel solutions for breast cancer patients

Dr Martina Wiitzel from Daiichi Sankyo considers the burden of breast cancer highlighting the impact it has on women, and the advances in breast cancer care and precision medicines

5 October 2023Industry Insights
Using genomics to uncover the causes of rare diseases and improve their treatment
Using genomics to uncover the causes of rare diseases and improve their treatment

Neil Ward from PacBio tells Pharmafocus about the use of whole genome sequencing in diagnosing and treating rare diseases, as well as considering other areas in which this could be utilised

5 October 2023Industry Insights